News & Analysis on Clinical Trial Services & Contract Research And Development
Cardinal Health has completed its $2 billion (€1.6bn) tender offer for intravenous product and services firm Alaris Medical Systems in a deal that could give Alaris a leg-up that will allow it to leapfrog its competitors.
Germany's Icon Genetics and Israeli firm Protalix are to collaborate on a way of hiking protein expression in plant cells to improve their use a production vehicle for recombinant proteins.
Chemical giant BASF is set to raise its European price for polystyrene (PS) by €200 per metric ton from 1 July this year in response to what it calls totally unsatisfactory margins and earnings.
Contract research manufacturer Diosynth has forged a joint venture with a Swiss firm for a technology that could dramatically reduce the time and cost of developing new cell lines for manufacturing proteins, writes Phil Taylor.